Evidence map›Paper›PMID 33535425›Full record

ArticleInternational journal of molecular sciences2021

Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.

Aimilia Eirini Papathanasiou, Fotios Spyropoulos, Zoe Michael, Kyoung E Joung, Despina D Briana, Ariadne Malamitsi-Puchner, Christos S Mantzoros, Helen Christou

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.Oxidative medicine and cellular longevity · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Aimilia Eirini PapathanasiouDepartment of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Fotios SpyropoulosDepartment of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Zoe MichaelHarvard Medical School, Boston, MA 02215, USA.ORCID 0000-0001-7318-0215
Kyoung E JoungDepartment of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Despina D BrianaDepartment of Pediatrics, National and Kapodistrian University of Athens Medical School, 10679 Athens, Greece.
Ariadne Malamitsi-PuchnerDepartment of Pediatrics, National and Kapodistrian University of Athens Medical School, 10679 Athens, Greece.
Christos S MantzorosHarvard Medical School, Boston, MA 02215, USA.
Helen ChristouDepartment of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Brigham and Women's Hospital · USNational and Kapodistrian University of Athens · GRBeth Israel Deaconess Medical Center · USBoston Children's Hospital · US

Funding

Neonatal Research Training ProgramT32HD098061 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Stella Kourembanas, Martha C. Sola-Visner · 2019 to 2026
$4.0M
NICHD NIH HHS T32 HD098061NIH HHS HL 116573NIH HHS HL123767NIH HHS T32 HD-098061
6 · The paper itself

Abstract

Pulmonary hypertension (PH) is associated with meta-inflammation related to obesity but the role of adipose tissue in PH pathogenesis is unknown. We hypothesized that adipose tissue-derived metabolic regulators are altered in human and experimental PH. We measured circulating levels of fatty acid binding protein 4 (FABP-4), fibroblast growth factor -21 (FGF-21), adiponectin, and the mRNA levels of FABP-4, FGF-21, and peroxisome proliferator-activated receptor γ (PPARγ) in lung tissue of patients with idiopathic PH and healthy controls. We also evaluated lung and adipose tissue expression of these mediators in the three most commonly used experimental rodent models of pulmonary hypertension. Circulating levels of FABP-4, FGF-21, and adiponectin were significantly elevated in PH patients compared to controls and the mRNA levels of these regulators and PPARγ were also significantly increased in human PH lungs and in the lungs of rats with experimental PH compared to controls. These findings were coupled with increased levels of adipose tissue mRNA of genes related to glucose uptake, glycolysis, tricarboxylic acid cycle, and fatty acid oxidation in experimental PH. Our results support that metabolic alterations in human PH are recapitulated in rodent models of the disease and suggest that adipose tissue may contribute to PH pathogenesis.

Indexed as

AdipokinesAdiponectinAdultAnimalsCase-Control StudiesFatty Acid-Binding ProteinsFemaleFibroblast Growth FactorsGlycolysisHemodynamicsHumansHypertension, PulmonaryMaleMiddle AgedPPAR gammaPulmonary Arterial HypertensionAdipokinesAdiponectinADIPOQ protein, humanFABP4 protein, humanFatty Acid-Binding ProteinsFGF21 protein, humanFibroblast Growth FactorsPPAR gammaPPARG protein, humanadipose tissuemeta-inflammationpulmonary hypertension

Identifiers

PMID33535425
PMCPMC7867052
OpenAlexW3127450275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.